Uniphar (LSE:UPR) Beneish M-Score: -2.44 (As of Jun. 26, 2026)


LSE:UPR Uniphar PLC LSE:UPR
82 GF Score
Price £3.93
GF Value £3.03
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Uniphar Beneish M-Score?

Uniphar LSE:UPR -4.15% 82 Beneish M-Score is -2.44 as of Jun. 26, 2026. GuruFocus rates LSE:UPR with a GF Score™ of 82/100 and a GF Value™ of £3.03 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 113 Medical Distribution companies, Uniphar ranks worse than 53.98% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.44 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Uniphar's Beneish M-Score or its related term are showing as below:

LSE:UPR' s Beneish M-Score Range Over the Past 10 Years
Min: -3.23   Med: -2.54   Max: -1.92
Current: -2.44

During the past 10 years, the highest Beneish M-Score of Uniphar was -1.92. The lowest was -3.23. And the median was -2.54.


Uniphar Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Uniphar's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Uniphar Beneish M-Score Chart

Uniphar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.40 -2.65 -2.23 -2.63 -2.44

Uniphar Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.23 0.00 -2.63 0.00 -2.44

LSE:UPR vs MCK, COR, CAH: Beneish M-Score Comparison

For the Medical Distribution subindustry, Uniphar's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Uniphar Beneish M-Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Uniphar's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Uniphar's Beneish M-Score falls into.


LSE:UPR
82GF Score
Uniphar PLC LSE:UPR
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Uniphar Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Uniphar for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1642+0.528 * 1.0369+0.404 * 0.8526+0.892 * 1.172+0.115 * 1.042
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.963+4.679 * -0.033103-0.327 * 1.0778
=-2.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was £268 Mil.
Revenue was £2,689 Mil.
Gross Profit was £400 Mil.
Total Current Assets was £725 Mil.
Total Assets was £1,515 Mil.
Property, Plant and Equipment(Net PPE) was £263 Mil.
Depreciation, Depletion and Amortization(DDA) was £31 Mil.
Selling, General, & Admin. Expense(SGA) was £321 Mil.
Total Current Liabilities was £730 Mil.
Long-Term Debt & Capital Lease Obligation was £429 Mil.
Net Income was £45 Mil.
Gross Profit was £0 Mil.
Cash Flow from Operations was £95 Mil.
Total Receivables was £197 Mil.
Revenue was £2,295 Mil.
Gross Profit was £354 Mil.
Total Current Assets was £459 Mil.
Total Assets was £1,173 Mil.
Property, Plant and Equipment(Net PPE) was £236 Mil.
Depreciation, Depletion and Amortization(DDA) was £29 Mil.
Selling, General, & Admin. Expense(SGA) was £284 Mil.
Total Current Liabilities was £522 Mil.
Long-Term Debt & Capital Lease Obligation was £310 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(268.196 / 2689.466) / (196.556 / 2294.669)
=0.099721 / 0.085658
=1.1642

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(354.173 / 2294.669) / (400.347 / 2689.466)
=0.154346 / 0.148857
=1.0369

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (725.063 + 263.429) / 1515.22) / (1 - (458.656 + 235.889) / 1172.698)
=0.347625 / 0.407738
=0.8526

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2689.466 / 2294.669
=1.172

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(29.291 / (29.291 + 235.889)) / (31.237 / (31.237 + 263.429))
=0.110457 / 0.106008
=1.042

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(320.628 / 2689.466) / (284.059 / 2294.669)
=0.119216 / 0.123791
=0.963

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((428.918 + 730.251) / 1515.22) / ((309.988 + 522.402) / 1172.698)
=0.765017 / 0.709808
=1.0778

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(44.687 - 0 - 94.845) / 1515.22
=-0.033103

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Uniphar has a M-score of -2.38 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.44 mean?
Uniphar (LSE:UPR) has a Beneish M-Score of -2.44 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Uniphar and its competitors. According to the industry distribution chart, Uniphar ranks #61 out of 113 companies in the Medical Distribution industry, placing it in the top 54%.
Is Uniphar's Beneish M-Score too high?
Uniphar's current Beneish M-Score is -2.44. Based on the distribution chart, Uniphar ranks #61 out of 113 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Uniphar has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Uniphar's Beneish M-Score compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Uniphar ranks #61 out of 113 companies for Beneish M-Score. This places Uniphar in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Distribution company?
A good Beneish M-Score depends on the Medical Distribution industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Uniphar and its competitors. Uniphar's current Beneish M-Score is -2.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Uniphar stock overvalued right now?
Based on GuruFocus' analysis, Uniphar (LSE:UPR) is currently considered Modestly Overvalued. The stock's GF Value™ is £3.03, compared to a current price of £3.93 — trading 29.7% above its estimated fair value. The current Beneish M-Score is -2.44. Uniphar's overall GF Score™ is 82/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Uniphar (LSE:UPR), the current Beneish M-Score is -2.44 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Uniphar (LSE:UPR) Overvalued in 2026?

Based on GuruFocus' analysis, Uniphar stock appears to be overvalued. The current stock price of £3.93 is trading 29.7% above its estimated GF Value™ of £3.03. GuruFocus considers Uniphar to be Modestly Overvalued.

Key valuation signals for LSE:UPR:

  • Beneish M-Score: -2.44
  • GF Value™: £3.03 vs. price of £3.93 (29.7% above fair value)
  • GF Score™: 82/100 with 9 warning signs

No single metric tells the full story. See the LSE:UPR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Uniphar Business Description

Other Exchanges UPR:Ireland0NR:Germany
Address 4045 Kingswood Road, Citywest Business Park, Dublin, IRL, D24 V06K
Uniphar PLC is a service provider within the pharmaceutical and healthcare sector. The company is an international diversified healthcare services business servicing the requirements of multinational pharmaceutical and medical technology manufacturers across three divisions - Uniphar Pharma, Uniphar Medtech and Uniphar Supply Chain & Retail. Uniphar Pharma enables pharma and biotech companies to bring medicines to markets globally and provide healthcare professionals with access to medicines that can't be sourced through traditional channels. Uniphar Medtech is a Pan-European medical device distributor and solutions partner. Uniphar Supply Chain & Retail is the pharmaceutical wholesaler in Ireland offering of retail pharmacies.
82GF Score

Get the complete analysis for LSE:UPR

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£3.93
Price
£3.03
GF Value